CATALYTICA PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
CATALYTICA PHARMACEUTICALS, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALOPRIM. The owner is based in Mountain View, CA.
430 Ferguson Drive
Mountain View, CA 940435272
Showing of trademarks Trademarks
Trademark Classifications
CATALYTICA PHARMACEUTICALS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CATALYTICA PHARMACEUTICALS, INC. have?
CATALYTICA PHARMACEUTICALS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 3 cancelled.
What trademark classes does CATALYTICA PHARMACEUTICALS, INC. file in?
CATALYTICA PHARMACEUTICALS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are CATALYTICA PHARMACEUTICALS, INC.'s most well-known trademarks?
CATALYTICA PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as ALOPRIM. These are among 1 currently registered trademark in the portfolio.
What is CATALYTICA PHARMACEUTICALS, INC.'s trademark registration success rate?
CATALYTICA PHARMACEUTICALS, INC. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.